Re:Cognition Health - Chicago — Chicago, Illinois

Re:Cognition Health - Chicago is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Re:Cognition Health - Chicago has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Alzheimer's Disease, Alzheimer Disease, Opioid Use Disorder.

Sponsors: Eli Lilly and Company, AriBio Co., Ltd., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Re:Cognition Health - Chicago?

Re:Cognition Health - Chicago has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Re:Cognition Health - Chicago conducted?

Re:Cognition Health - Chicago has 7 clinical trials on record, with 7 currently active. Their work covers Alzheimer's Disease, Alzheimer Disease, Opioid Use Disorder.

Is Re:Cognition Health - Chicago accredited by Crixeo Health?

Re:Cognition Health - Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Re:Cognition Health - Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.